Literature DB >> 27402220

Utility of a standardized protocol for submitting clinically suspected endometrial polyps to the pathology laboratory.

Nida S Safdar1, Giovanna A Giannico1, Mohamed Mokhtar Desouki2.   

Abstract

The purpose of the study is to assess whether a protocol for submitting clinically suspected endometrial polyps will improve the detection rate of polyps and evaluation of the background endometrium. A retrospective review from 1999 to 2015 was performed. Cases were divided into (1) polyps and curettings placed in 2 containers (separate, n=61) and (2) polyps and curettings placed in 1 container (combined, n=80). Polyps were identified in 100% of cases in the separate compared with 95% in the combined group (P=.62). The background endometrium was evaluable in 79% of cases in the combined compared to 90% in the separate group (P=.07). The frequency of hyperplasia without atypia, atypical hyperplasia, and carcinoma was 4.4%, 3.6%, and 1.5%, respectively. In conclusion, the enhanced rate of polyp detection and evaluation of the background endometrium in the separate group is minimal. This supports the recommendation of submitting endometrial polyps and curettings combined in 1 container.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carcinoma; Containers; Endometrial polyp; Evaluation; Hyperplasia; Protocol

Mesh:

Year:  2016        PMID: 27402220      PMCID: PMC4959454          DOI: 10.1016/j.anndiagpath.2016.05.002

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  11 in total

1.  Predictors of malignancy in endometrial polyps: a multi-institutional cohort study.

Authors:  P Litta; J Di Giuseppe; L Moriconi; G Delli Carpini; M G Piermartiri; A Ciavattini
Journal:  Eur J Gynaecol Oncol       Date:  2014       Impact factor: 0.196

2.  Clinicopathologic findings in endometrial polyps.

Authors:  L J Van Bogaert
Journal:  Obstet Gynecol       Date:  1988-05       Impact factor: 7.661

Review 3.  The oncogenic potential of endometrial polyps: a systematic review and meta-analysis.

Authors:  Stephanie Cruz Lee; Andrew M Kaunitz; Luis Sanchez-Ramos; Ronald M Rhatigan
Journal:  Obstet Gynecol       Date:  2010-11       Impact factor: 7.661

Review 4.  Diagnosis and management of endometrial polyps: a critical review of the literature.

Authors:  S Salim; H Won; E Nesbitt-Hawes; N Campbell; J Abbott
Journal:  J Minim Invasive Gynecol       Date:  2011-07-23       Impact factor: 4.137

5.  Evaluation of endometrial polyps.

Authors:  Steven R Goldstein; Ana Monteagudo; Dorota Popiolek; Pat Mayberry; Ilan Timor-Tritsch
Journal:  Am J Obstet Gynecol       Date:  2002-04       Impact factor: 8.661

6.  Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps.

Authors:  Luca Savelli; Pierandrea De Iaco; Donatella Santini; Federica Rosati; Tullio Ghi; Elettra Pignotti; Luciano Bovicelli
Journal:  Am J Obstet Gynecol       Date:  2003-04       Impact factor: 8.661

7.  A restraining device and oral dosing technic for the chinchilla (Chinchilla laniger).

Authors:  H C Strout
Journal:  Lab Anim Sci       Date:  1976-08

8.  Malignancy in endometrial polyps: a 12-year experience.

Authors:  Gabriela Baiocchi; Natalina Manci; Michela Pazzaglia; Laura Giannone; Liliana Burnelli; Ettore Giannone; Daniela Fratini; Gian Carlo Di Renzo
Journal:  Am J Obstet Gynecol       Date:  2009-07-26       Impact factor: 8.661

9.  Endometrial polyps and the risk of atypical hyperplasia on biopsies of unremarkable endometrium: a study on 694 patients with benign endometrial polyps.

Authors:  Siavash Rahimi; Carla Marani; Cristina Renzi; Maria Emanuela Natale; Paolo Giovannini; Renato Zeloni
Journal:  Int J Gynecol Pathol       Date:  2009-11       Impact factor: 2.762

10.  Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy.

Authors:  A Antunes; L Costa-Paiva; M Arthuso; J V Costa; A M Pinto-Neto
Journal:  Maturitas       Date:  2007-06-22       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.